To test if GHSR methylation signature is of diagnostic value for other tumors, seven common malignancies were chosen, namely cancers of breast, lung, pancreas, prostate, colorectum as well as the most common lymphoproliferative disease CLL. Here, GHSR is linked to B-cell chronic lymphocytic leukemia.